Annual Cash & Cash Equivalents
$169.68 M
+$155.08 M+1062.04%
December 31, 2023
Summary
- As of February 7, 2025, SLNO annual cash & cash equivalents is $169.68 million, with the most recent change of +$155.08 million (+1062.04%) on December 31, 2023.
- During the last 3 years, SLNO annual cash & cash equivalents has risen by +$120.46 million (+244.71%).
- SLNO annual cash & cash equivalents is now at all-time high.
Performance
SLNO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$48.41 M
-$8.61 M-15.10%
September 30, 2024
Summary
- As of February 7, 2025, SLNO quarterly cash and cash equivalents is $48.41 million, with the most recent change of -$8.61 million (-15.10%) on September 30, 2024.
- Over the past year, SLNO quarterly cash and cash equivalents has dropped by -$4.02 million (-7.67%).
- SLNO quarterly cash and cash equivalents is now -71.47% below its all-time high of $169.68 million, reached on December 31, 2023.
Performance
SLNO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SLNO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1062.0% | -7.7% |
| 3 y3 years | +244.7% | -7.7% |
| 5 y5 years | +634.6% | -7.7% |
SLNO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1062.0% | -71.5% | +514.9% |
| 5 y | 5-year | at high | +1062.0% | -71.5% | +514.9% |
| alltime | all time | at high | >+9999.0% | -71.5% | >+9999.0% |
Soleno Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $48.41 M(-15.1%) |
| Jun 2024 | - | $57.02 M(+33.1%) |
| Mar 2024 | - | $42.85 M(-74.7%) |
| Dec 2023 | $169.68 M(+1062.0%) | $169.68 M(+223.6%) |
| Sep 2023 | - | $52.44 M(+170.7%) |
| Jun 2023 | - | $19.37 M(+146.0%) |
| Mar 2023 | - | $7.87 M(-46.1%) |
| Dec 2022 | $14.60 M(-31.5%) | $14.60 M(-26.1%) |
| Sep 2022 | - | $19.75 M(-17.9%) |
| Jun 2022 | - | $24.07 M(-16.9%) |
| Mar 2022 | - | $28.97 M(+36.0%) |
| Dec 2021 | $21.30 M(-56.7%) | $21.30 M(-24.4%) |
| Sep 2021 | - | $28.18 M(-16.1%) |
| Jun 2021 | - | $33.60 M(-19.3%) |
| Mar 2021 | - | $41.61 M(-15.5%) |
| Dec 2020 | $49.22 M(+137.4%) | $49.22 M(-12.3%) |
| Sep 2020 | - | $56.14 M(-10.2%) |
| Jun 2020 | - | $62.50 M(+314.7%) |
| Mar 2020 | - | $15.07 M(-27.3%) |
| Dec 2019 | $20.73 M | $20.73 M(+84.7%) |
| Sep 2019 | - | $11.22 M(-27.6%) |
| Jun 2019 | - | $15.50 M(-20.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $19.40 M(-16.0%) |
| Dec 2018 | $23.10 M(+35.1%) | $23.10 M(+125.6%) |
| Sep 2018 | - | $10.24 M(-18.7%) |
| Jun 2018 | - | $12.59 M(-15.3%) |
| Mar 2018 | - | $14.87 M(-13.1%) |
| Dec 2017 | $17.10 M(+527.3%) | $17.10 M(+202.8%) |
| Sep 2017 | - | $5.65 M(-25.2%) |
| Jun 2017 | - | $7.55 M(-28.4%) |
| Mar 2017 | - | $10.54 M(+286.6%) |
| Dec 2016 | $2.73 M(-50.4%) | $2.73 M(-49.7%) |
| Sep 2016 | - | $5.42 M(+116.4%) |
| Jun 2016 | - | $2.50 M(-61.5%) |
| Mar 2016 | - | $6.49 M(+18.2%) |
| Dec 2015 | $5.49 M(-30.9%) | $5.49 M(+16.4%) |
| Sep 2015 | - | $4.72 M(-37.3%) |
| Jun 2015 | - | $7.53 M(-21.0%) |
| Mar 2015 | - | $9.53 M(+19.8%) |
| Dec 2014 | $7.96 M(+527.1%) | $7.96 M(>+9900.0%) |
| Sep 2014 | - | $64.00 K(-94.7%) |
| Jun 2014 | - | $1.21 M(+58.1%) |
| Mar 2014 | - | $763.90 K(-39.8%) |
| Dec 2013 | $1.27 M(-41.1%) | $1.27 M |
| Dec 2012 | $2.16 M | - |
FAQ
- What is Soleno Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Soleno Therapeutics?
- What is Soleno Therapeutics annual cash & cash equivalents year-on-year change?
- What is Soleno Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Soleno Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SLNO is $169.68 M
What is the all time high annual cash & cash equivalents for Soleno Therapeutics?
Soleno Therapeutics all-time high annual cash & cash equivalents is $169.68 M
What is Soleno Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SLNO annual cash & cash equivalents has changed by +$155.08 M (+1062.04%)
What is Soleno Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SLNO is $48.41 M
What is the all time high quarterly cash and cash equivalents for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly cash and cash equivalents is $169.68 M
What is Soleno Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, SLNO quarterly cash and cash equivalents has changed by -$4.02 M (-7.67%)